brevets smith


  1. Pyrazolo[1,5-a]-1,3,5-triazine as a purine bioisostere: access to potent cyclin-dependent kinase inhibitor (R)-roscovitine analogue. Popowycz, F.; Fournet, G.; Schneider, C.; Bettayeb, K.; Ferandin, Y.; Lamigeon, C.; Tirado, O. M.; Mateo-Lozano, S.; Notario, V.; Colas, P.; Bernard, P.; Meijer, L.; Joseph, B. J. Med. Chem. 2009, 52, 655-663.
  2. Unexpected C2-arylation of 1-(pyridin-2-yl)indole-3-carboxaldehyde mediated by copper. Sagnes, C.; Fournet, G.; Joseph, B. Synlett 2009, 433-436.
  3. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives. Popowycz, F.; Schneider, C.; DeBonis, S.; Skoufias, D. A.; Kozielski, F.; Galmarini, C. M.; Joseph, B. Bioorg. Med. Chem. 2009, 17, 3471-3478.
  4. Synergetic bitherapy in mice with xenografts of human prostate cancer using a methional mimic (METLICO) and an aldehyde dehydrogenase 3 inhibitor (MATE): systemic intraperitoneal (IP) and targeted intra-tumoral (IT) administration. Hiltbrand, E.; Fournet, G.; Giliberto, J.-P.; Paret, M.-J.; Chantepie, J.; Morel, D.; Gore, J.; Reichert, U.; Mehier, H.; Rochedix, M.-E.; Quash, G. Curr. Med. Chem. 2009, 16, 1184-1191.
  5. New Insights in the Homopiperazine-based 5-HT1A/5-HT7R ligands: Synthesis and biological evaluation. Badarau, E.; Putey, A.; Suzenet, F.; Joseph, B.; Bojarski, A. J.; Fînaru, A.-L.; Guillaumet, G. J. Enz. Inhib. Med. Chem. 2009, 25, 301-305.
  6. Indolobenzazepin-7-ones and 6-, 8- and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure-activity relationships. Putey, A.; Popowycz, F.; Do, Q.-T.; Bernard, P.; Talapatra, S. K.; Kozielski, F.; Galmarini, C. M.; Joseph,J. Med. Chem. 2009, 52, 5916-5925.
  7. Methionine-derived metabolites in apoptosis: therapeutic opportunities for inhibitors of their metabolism in chemoresistant cancer cells. Quash, G.; Fournet, G.
  8. Chemoselective functionalization of α-carbolines at the C-2, C-3, C-4 and C-6 positions using Suzuki-Miyaura reactions. Schneider, C.; Gueyrard, D.; Joseph, B.; Goekjian, P. G. Tetrahedron 2009, 65, 5427-5437.
  9. A simple access to metallic or onium bistrifluoromethanesulfonimide salts. Arvai, R.; Toulgoat, F.; Langlois, B. R.; Sanchez, J-.Y.; Médebielle, M. Tetrahedron 2009, 65, 5361-5368.
  10. An efficient and selective synthetic method for fluorine-containing benzo[h]quinolines and 1H-benzo[h]quinolin-2-ones from N-propargyl-2,4-bis(trifluoroacetyl)-1-naphthylamine. Okada,
  11. Fluorine-containing 1,10-phenanthrolines synthesis: an original and efficient approach by the pyridine-ring formation reaction of N-propargyl-5,7-bis(trifluoroacetyl)-8-quinolylamine with various nucleophiles. Shibata, D.; Okada, E.; Molette, J.; Médebielle, M. Tetrahedron 2009, 65, 6189-6195
  12. A facile synthetic method for fluorine-containing 1,7-phenanthrolines: pyridine-ring formation reaction of N-propargyl-6,8-bis(trifluoroacetyl)-5-quinolylamine with various nucleophiles. Shibata, D.; Okada, E.; Hinoshita, M.; Médebielle, M. Synthesis 2009, 3039-3046.
  13. Single end-to-end azidocopper(II) chain based on an electroactive ligand: a structural, electrochemical, magnetic and ab initio study. Pilet, G.; Médebielle, M.; Tommasino, J.-B.; Chastanet, G.; Le Guennic, B.; Train, C. Eur. J. Inorg. Chem. 2009, 4718-4726.
  14. MicroRNA machinery is an integral component of drug-induced transcription inhibition in HIV-1 infection, Carpio, L.; Klase, Z.; Coley, W.; Guendel, I.; Choi, S.; Van Duyne, R.; Narayanan, A.; Khen-Hall, K.; Galons, H.; Oumata, N.; Joseph, B.; Meijer, L.; Kashanchi, F. J. RNAi Gene Silencing 2010, 6, 386-400.
  15. Synthesis of 2-, 3- and 4-substituted pyrido[2,3-b]indoles by C-N, C-O and C-C(sp) bond formation. Schneider, Goyard, D.; Gueyrard, D.; Joseph, B.; Goekjian, P. G. Eur. J. Org. Chem. 2010, 6665-6677.
  16. A concise synthesis of fluorine-containing benzo[h]quinolines and benzo[h]quinolones by selective pyridine and pyridinone rings formation reactions of N-propargyl-2,4-bis(trifluoroacetyl)-1-naphthylamine with various active methylene compounds. Okada, E.; Shibata, D.; Tsukushi, N.; Dohura, M.; Ota, N.; Adachi, S.; Médebielle, M. Heterocycles 2010, 81, 357-370.
  17. Direct aldol – reduction process using difluoromethyl ketones and aryl aldehydes in the presence of potassium tert-Butoxide: one-pot efficient stereoselective synthesis of symmetrical and unsymmetrical anti-2,2-difluoropropane-1,3-diols. Xu, W.; Médebielle, M.; Bellance, M.-H.; Dolbier, W. R., Jr. Adv. 2010, 352, 2787-2790.
  18. A facile synthesis of fluorine-containing 1,7-phenanthrolines by the cyclization of N-propargyl-6,8-bis(trifluoroacetyl)quinolin-5-amine with various active methylene compounds. Shibata, D.; Sakai, A.; Hatakenaka, M.; Saikawa, S.; Kamitori, Y.; Médebielle, M.; Okada E. Heterocycles 2010, 82, 803-812.
  19. Structure-activity relationship and multidrug resistance of newS-trityl-L-cysteine derivatives as inhibitors of Eg5.Kaan,H. Y. K.; Weiss, J.; Menger, D.; Ulaganathan, V.; Tkocz, K.; Laggner, C.; Popowycz, F.; Joseph, B.; Kozielski, F.J. Med. Chem. 2011, 54, 1576-1586.
  20. Unexpected matrix interactions in liquid secondary ion mass spectrometry of two pyranosylmercaptans. Gardrat, C.; Joseph, B.; Vitry, C.; Castellan, A.; Rollin, P. Rapid Commun. Mass Spectrom. 2011, 25, 1399-1406.
  21. Chopin, N.; Decamps, S.; Gouger, A.; Médebielle, M.; Picot, S.; Bienvenu, A.-L.; Pilet, G., J. Fluorine. 2011, 132, 850-857.
  22. Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Boyer, J.; Arnoult, E.; Médebielle, M.; Guillemont, J.; Unge, J.; Jochmans, D. J. Med. Chem. 2011, 54, 7974-7985.
  23. Syntheses of a wide family of new aryl based perflurosulfonimide lithium salts. Electrochemical performances of the related polymer electrolytes. Paillard, E.; Toulgoat, F.; Arvai, R.; Iojoiu, L.; Cointeaux, C.; Médebielle, M.; Alloin, F.; Langlois B.; Sanchez. J.-Y. J. Fluorine. Chem. 2011, 132, 1213-1218.
  24. Targeting Low Molecular Weight Cyclin E (LMW-E) in Breast Cancer. Nanos-Webb, A.; Jabour, N. A.; Multani, A. S.; Wingate, H.; Oumata, N.; Galons, H.; Joseph, B.; Meijer, L.; Hunt, K. K.; Keyomarsi, K. Breast Cancer Res. Treat. 2012, 132, 575-588.
  25. Inhibition of Hepatitis C Virus NS5B Polymerase by S-Trityl-L-cysteine Derivatives. Nichols, D. B.; Fournet, G.; Gurukumar, K. R.; Basu, A.; Lee, J.-C.; Sakamoto, N.; Kozielski, F.; Musmuca, I.; Joseph, B.; Ragno, R.; Kaushik-Basu, N. Eur. J. Med. Chem. 2012, 49, 191-199.
  26. Use of ATP analogs to inhibit HIV-1 transcription, Narayanan, A.; Sampey, G.; Van Duyne, R.; Guendel, I.; Kehn-Hall, K.; Roman, J.; Currer, R.; Galons, H.; Oumata, N.; Joseph, B.; Meijer, L.; Caput, M.; Nekhai, S.; Kashanchi, F. Virology 2012, 432, 219-231.
  27. A facile and convenient method for the synthesis of 6,8-bis(trifluoroacetyl)quinoline-5-ones. Shibata, D.; Médebielle, M.; Hatakenaka, M.; Okada E. Heterocycles 2012, 84, 1277-1284.
  28. Polymer electrolytes based on new aryl-containing lithium perfluorosulfonates. Paillard, E.; Toulgoat, F.; Iojoiu, C.; Alloin, F.; Guindet, J.; Médebielle, M.; Langlois B.; Sanchez, J.-Y. 2012, 134, 72-76.
  29. Bidentate and tetradentate b-aminovinyl trifluoromethylated ketones and their copper(II) complexes: synthesis, characterization and redox chemistry. Chopin, N.; Médebielle, M.; Pilet, G. 2012, 1093-1103.
  30. Copper(II) cubane complexes built from electro- and photo-sensitive b-aminovinyl trifluoromethyl ketone ligands. Chopin, N.; Chastanet, G.; Le Guennic, B.; Médebielle, M.; Pilet, G. Eur. J. Inorg. Chem. 2012, 5058-5070.
  31. Recent advances in the synthesis and properties of 4-, 5-, 6-, 7-azaindoles. Merour, J.-Y.; Routier, S.; Suzenet, F.; Joseph, Tetrahedron 2013, 69, 4767-4834.
  32. α,β-acetylenic amino thiolester inhibitors of aldehyde dehydrogenases 1&3: suppressors of apoptogenic aldehyde oxidation and activators of apoptosis. Fournet, G.; Martin, G.; Quash, G. Curr. Med. Chem. 2013, 20, 527-533.
  33. Incorporation of a 3-(2,2,2-trifluoroethyl)-g-hydroxy-g-lactam motif in the side chain of 4-aminoquinolines. Syntheses and antimalarial activities. Cornut, D.; Lemoine, H.; Kanishchev, O.; Okada, E.; Albrieux, F.; Beavogui, A. H.; Bienvenu, A.-L.; Picot, S.; Bouillon, J.-P.; Médebielle,M. J. Med. Chem. 2013, 56, 73-83.
  34. Catalytic hydrotrifluoromethylation of unactivated alkenes. Mizuta, S.; Verhoog, S.; Engle, K. M.; Khotavivattana, T.; O’Duill, M.; Wheelhouse, K.; Rassias, G.; Médebielle, M.; Gouverneur, V. J. Am. Chem. Soc. 2013, 135, 2505-2508.
  35. Trifluoromethylation of allylsilanes under photoredox catalysis. Mizuta, S.; Engle, K. M.; Verhoog, S.; Lopez, O. G.; O’Duill, M.; Médebielle, M.; Wheelhouse, K.; Rassias, G.; Thompson, A. L.; Gouverneur, V. Org. Lett. 2013, 15, 1250-1253.
  36. Regioselective bromination of tetronic acid-derived g-lactones and metal-catalyzed post-functionalization. An efficient access to new g-ylidenetetronate derivatives. Iikawa, S.; Chopin, N.; Pilet, G.; Bouillon, J.-P.; Médebielle, M. Tetrahedron Lett. 2013, 54, 4577-4581.
  37. 8-Aminoquinoline and 2-aminopyridine trifluoromethyl-derived enaminone ligands and their Co(II), Ni(II) and Zn(II) metal complexes: structural arrangements due to F-H interactions. Chopin, N.; Pilet, G.; Médebielle, M. J. Fluorine. Chem. 2013, 155, 89-96.
  38. Redox chemistry of trifluoromethyl sulfonium salts as CF3 radical sources. Mizuta, S.; Verhoog, S.; Wang, X.; Shibata, N.; Gouverneur, V.; Médebielle, M. J. Fluorine. 2013, 155, 124-131.
  39. New route to the 5-((arylthio- and heteroarylthio)methylene)-3-(2,2,2-trifluoroethyl)-furan-2(5H)-ones - Key intermediates in the synthesis of 4-aminoquinoline -lactams as potent antimalarial compounds. Kanishchev, O.; Lavoignat, A.; Picot, S.; Médebielle, M.; Bouillon, J.-P. Bioorg. Med. Chem. Lett. 2013, 23, 6167-6171.
  40. New N-arylindoles based serotonin 5-HT7 ligands. Synthesis and binding evaluation studies. Sagnes, C.; Fournet, G.; Satala, G.; Bojarski, A.; Joseph, B. Eur. J. Med. 2014, 75, 159-168.
  41. Synthesis and biological evaluation of tetrahydro[1,4]diazepino[1,2-a]indol-1-ones as cyclin-dependent kinase inhibitors. Putey, A.; Fournet, G.; Lozach, O.; Perrin, L.; Meijer, L.; Joseph, B. Eur. J. Med. Chem. 2014, 83, 617-629.
  42. Trifluoromethyl-derived enaminones and their difluoroboron complexes: synthesis, crystal structure and electrochemistry properties. Chopin, N.; Pilet, G.; Morita, Y.; Médebielle, M. J. Fluorine. Chem. 2014, 167, 211-225.
  43. Impact of meriolins, a new class of cyclin-dependent kinase inhibitors, on malignant glioma proliferation and neo-angiogenesis. Jarry, M.; Lecointre, C.; Malleval, C.; Desrues, L.; Schouft, M.-T.; Lejoncour, V.; Liger, F.; Lyvinec, G.; Joseph, B.; Loaëc, N.; Meijer, L.; Honnorat, J.; Gandolfo, P.; Castel, H. Neuro Oncol. 2014, 16, 1484-1498.
  44. Quenching of fluorescence in bodipy-derived trifluoromethyl enaminone ligands upon coordination to copper(II). Chopin, N.; Médebielle, M.; Maury, O.; Novitchi, G.; Pilet, G. Eur. J. Inorg. Chem. 2014, 6185-6195.


  1. A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria. Picot, S.; Olliaro, P.; de Monbrison, F.; Bienvenu, A. L.; Price, R.; Ringwald, P. Malaria J. 2009, 8, 89.
  2. Epoietin beta-Quinine drug combination in children with cerebral malaria in Mali. Picot, S.; Bienvenu, A. L.; Konate, S.; Sissoko, S.; Barry, A.; Diarra, E.; Bamba, K.; Djimde, A.; Doumbo, O. K. Malaria J. 2009, 8, 169.
  3. Malaria. Picot, S. Rev. Prat. 2009, 59, 1135-1141.
  4. Analysis of diluted vitreous samples from vitrectomy is useful in eyes with severe acute postoperative endophthalmitis. Chiquet, C.; Maurin, M.; Thuret, G.; Benito, Y.; Cornut, P. L.; Creuzot-Garcher, C.; Rouberol, F.; Pechinot, A.; Lina, G.; Romanet, J. P.; Bron, A.; Vandenesch, F. and the French Institutional Endophthalmitis Group (Picot, S.) Ophthalmology 2009, 116, 2437-2441.
  5. Plasmodium vivax infection: not so benign. Picot, S.; Bienvenu, A. L. Med. Sci. (Paris) 2009, 25, 622-626.
  6. High prevalence and fixation of Plasmodium vivax dhfr/dhps mutations related to sulfadoxine/pyrimethamine resistance in French Guiana. Barnadas, C.; Musset, L.; Legrand, E.; Tichit, M.; Briolant, S.; Fusai, T.; Rogier, C.; Bouchier, C.; Picot, S.; Ménard, D. Am. J. Trop. Med. Hyg. 2009, 81, 19-22.
  7. Can erythropoietin be used to prevent brain damage in cerebral malaria? Casals-Pascual, C.; Idro, R.; Picot, S.; Roberts, D. J.; Newton, C. R. Trends Parasitol. 2009, 25, 30-36.
  8. 5th Multilateral Initiative on Malaria meeting. Une réunion mondiale pour de nouveaux espoirs? Bienvenu, A. L. Parasite 2010, 17, 166.
  9. Management of invasive aspergillosis in patients with COPD: rational use of voriconazole. Ader, F.; Bienvenu, A. L.; Rammaert, B.; Nseir, X. Int. J. Chron. Obstruct. Pulmon. Dis. 2009, 4, 279-287.
  10. Acute liver failure may lead to lethal pulmonary aspergillosis. Bienvenu, A. L.; Walter, T.; Boulez, F.; Faure, A. C.; Ber, C. E.; Allaouchiche, B.; Dumortier, J.; Picot, S. J. Clin. 2010, 44, 593-594.
  11. International, Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole. Lortholary, O.; Obenga, G.; Biswas, P.; Caillot, D.; Chachaty, E.; Bienvenu, A. L.; Cornet, M.; Greene, J.; Herbrecht, R.; Lacroix, C.; Grenouillet, F.; Raad, I.; Sitbon, K.; Troke, P.; 2010, 54, 4446-4450.
  12. Apoptosis induced by parasitic diseases. Bienvenu, A. L.; Gonzalez-Rey, E.; Picot, S. Parasit Vectors 2010, 3, 106.
  13. Severe Imported Malaria in Adults (SIMA) Study Group. Severe imported falciparum malaria: a cohort study in 400 critically ill adults. Bruneel, F.; Tubach, F.; Corne, P.; Megarbane, B.; Mira, J. P.; Peytel, E.; Camus, C.; Schortgen, F.; Azoulay, E.; Cohen, Y.; Georges, H.; Meybeck, A.; Hyvernat, H.; Trouillet, J. L.; Frenoy, E.; Nicolet, L.; Roy, C.; Durand, R.; Le Bras, J.; Wolff, M.and collaborators of the SIMA Study Group (Picot, S.) PLoS One 2010, 5, e13236.
  14. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. Beavogui, A. H.; Djimde, A. A.; Gregson, A.; Toure, A. M.; Dao, A.; Coulibaly, B.; Ouologuem, D.; Fofana, B.; Sacko, A.; Tekete, M.; Kone, A.; Niare, O.; Wele, M.; Plowe, C. V.; Picot, S.; Doumbo, O. K. Int. J. Parasitol. 2010, 40, 1213-1220.
  15. Are protozoan metacaspases potential parasite killers? Picot, S.; Zalila, H.; Meslin, B.; Fasel, N.; Bienvenu, A. L. Parasit Vectors 2011, 4, 26.
  16. Maxillary sinus fungal infection by Acremonium.Durbec, M.; Bienvenu, A. L.; Picot, S.; Dubreuil, C.; Cosmidis, A.; Tringali, S. . 2011, 128, 41-43.
  17. Risk factors for invasive aspergillosis in acute myeloid leukemia patients prophylactically treated with posaconazole. Michallet, M.; Morisset, S.; Kraghel, S.; Nicolini, F. E.; Thomas, X.; Sobh, M.; Bienvenu, A. L.; Picot, S.; Nicolle, M. C.; Vanhems, P. Med. Mycol. 2011, 49, 681-687.
  18. Primary cutaneous cryptococcosis in a liver transplant recipient. Ferry, T.; Moos, D.; Radenne, S.; Bienvenu, A. L.; Kanitakis, J. BMJ Case Reports, doi:10.1136/bcr.02.2011.3814.
  19. Invasive aspergillosis in patients with hematological malignancy: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Nicolle, M. C.; Bénet, T.; Thiebaut, A.; Bienvenu, A. L.; Voirin, N.; Duclos, A.; Sobh, M.; Cannas, G.; Thomas, X.; Nicolini, F.-E.; De Monbrison, F.; Piens, M.-A.; Picot, S.; Michallet, M.; Vanhems, P. Haematologica 2011, 96, 1685-1691.
  20. Imported acquired immunodeficiency syndrome-related histoplasmosis in metropolitan France: a comparison of pre-highly active anti-retroviral therapy and highly active anti-retroviral therapy eras. Peigne, V.; Dromer, F.; Elie, C.; Lidove, O.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Am. J. Trop. Med. Hyg. 2011, 85, 934-941.
  21. Plasmodium falciparum metacaspase PfMCA-1 triggers a z-VAD-fmk inhibitable protease to promote cell death. Meslin, B.; Beavogui, A. H.; Fasel, N.; Picot, S. PLoS One 2011, 6, e23867
  22. Update on genetic markers of quinine resistance in Plasmodium falciparum. Okombo, J.; Ohuma, E.; Picot, S.; Nzila, A. Mol. Biochem. Parasitol. 2011, 177, 77-82.
  23. Advantages and limits of real-time PCR assay and PCR-restriction fragment length polymorphism for the identification of cutaneous Leishmania species in Tunisia. Ben Abda, I.; de Monbrison, F.; Bousslimi, N.; Aoun, K.; Bouratbine, A.; Picot S. Trans. R. Soc. Trop. Med. Hyg. 2011, 105, 17-22.
  24. Candida spp. with acquired echinocandin resistance, France, 2004-2010. Dannaoui, E.; Desnos-Ollivier, M.; Garcia-Hermoso, D.; Grenouillet, F.; Cassaing, S.; Baixench, M. T.; Bretagne, S.; Dromer, F.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Emerg. Infect. Dis. 2012, 18, 86-90.
  25. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Lanternier, F.; Dannaoui, E.; Morizot, G.; Elie, C.; Garcia-Hermoso, D.; Huerre, M.; Bitar, D.; Dromer, F.; Lortholary, O. and the French Mycoses Study Group(Bienvenu, A. L.) Clin. Infect. Dis. 2012; 54, S35-43.
  26. Invasive Aspergillosis: An Important Risk Factor on Short and Long-term Survival of AML Patients. Michallet, M.; Bénet, T.; Sobh, M.; Kraghel, S.; El Hamri, M.; Cannas, G.; Nicolini, F. E.; Labussière, H.; Ducastelle, S.; Barraco, F.; Thomas, X.; Chelghoum, Y.; Nicolle, M. C.; Bienvenu, A. L.; Persat, F.; De Monbrison, F.; Picot, S.; Vanhems, P. Eur. J. Clin. Microbiol. 2012, 31, 991-997.
  27. Therapeutic Efficacy of Artemether-Lumefantrine treatment for Plasmodium falciparum and Plasmodium vivax infections in a prospective multicentre study in Guyana. Eibach, D.; Ceron, N.; Krishnalall, K.; Carter, K.; Ringwald, P.; Bonnot, G.; Bienvenu, A. L.; Picot, S. Malaria J. 2012, 11, 347.
  28. Cutaneous cryptococcosis in solid organ transplant recipients: epidemiological, clinical, diagnostic and therapeutic features.Biancheri, D.; Kanitakis, J.; Bienvenu, A. L.; Picot, S.; Morelon, E.; Faure, M.; Euvrard, S. 2012, 22, 651-657.
  29. Droplet Microfluidics Platform for Highly Sensitive and Quantitative Detection of Malaria Causing Plasmodium Parasites Based on Enzyme Activity Measurement. Juul, S.; Nielsen, C.; Labouria, R.; Roy, A.; Tesauro, C.; Jensen, P.; Harmsen, C.; Kristoffersen, E.; Chiu, Y. L.; Frøhlich, R.; Fiorani, P.; Cox, J.; Tordrup, D.; Koch, J.; Bienvenu, A. L.; Desideri, A.; Picot, S.; Petersen, E.; Leong, K.; Ho, Y. P.; Stougaard, M.; Knudsen, B. A. ACS Nano. 2012, 6, 10676-10683.
  30. Phaeohyphomycosis caused by Pyrenochaeta romeroi mimicking a plantar wart in a kidney transplant recipient.Ocampo, M. A.; Kanitakis, J.; Bienvenu, A. L.; Chauvet C.; Euvrard S. Transpl. 2012, 14, E173-E174.
  31. Good efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in eastern Sumba, East Nusatenggara, Indonesia. Sutanto, I.; Suprianto, S.; Widiaty, A.; Rukmiyati, X.; Ruckert, P.; von Bethmann, A.; de Monbrison, F.; Picot, S.; Laihad, F.; Baird, J. K. Acta Med. Indones. 2012, 44, 187-192.
  32. Utility of real-time PCR for the diagnosis of infantile visceral leishmaniasis in Algeria. Mihoubi, I.; de Monbrison, F.; Frahtia, K.; Picot, S.; Gassem, N. Med. Sante Trop. 2012, 22, 61-64.
  33. Ex vivo activity of the ACT new components pyronaridine and piperaquine in comparison with conventional ACT drugs against isolates of Plasmodium falciparum. Pascual, A.; Parola, P.; Benoit-Vical, F.; Simon, F.; Malvy, D.; Picot, S.; Delaunay, P.; Basset, D.; Maubon, D.; Faugère, B.; Ménard, G.; Bourgeois, N.; Oeuvray, C.; Didillon, E.; Rogier, C.; Pradines, B. Malaria J. 2012, 11, 45.
  34. Relationship between baseline clinical data and microbiologic spectrum in 100 patients with acute postcataract endophthalmitis. Cornut, P. L.; Thuret, G.; Creuzot-Garcher, C.; Maurin, M.; Pechinot, A.; Bron, A.; Gain, P.; Carricajo, A.; Denis, P.; Romanet, J. P.; Vandenesch, F.; Chiquet, C. and the French Institutional Endophthalmis Study Group (Picot, S.) Retina. 2012, 32, 549-557.
  35. The efficacy of voriconazole in 24 ocular Fusarium infections. Troke, P.; Obenga, G.; Gaujoux, T.; Goldschmidt, P.; Bienvenu, A. L.; Cornet, M.; Grenouillet, F.; Pons, D.; Ranque, S.; Sitbon, K.; Chaumeil, C.; Borderie, V.; Lortholary, O. Infection. 2013, 41, 15-20.
  36. Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011. Gharbi, M.; Flegg, J. A.; Hubert, V.; Kendjo, E.; Metcalf, J. E.; Bertaux, L.; Guérin, P. J.; Le Bras, J. and the Members of the French National Reference Centre for Imported Malaria Study (Picot, S.) Malaria J. 2013, 12, 35.
  37. Evaluation of the malaria rapid diagnostic test VIKIA malaria Ag Pf/Pan™ in endemic and non-endemic settings. Eibach, D.; Traore, B.; Bouchrik, M.; Coulibaly, B.; Coulibaly, N.; Siby, F.; Bonnot, G.; Bienvenu, A. L.; Picot, S. Malaria J. 2013, 12, 188.
  38. A multicentre, randomized, open label, controlled study comparing the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution with amorolfine nail alone in dermatophytic onychomycosis. Paul, C.; Coustou, D.; Lahfa, M.; Bulai-Livideanu, C.; Doss, N.; Mokthar, I.; Turki, H.; Nouira, R.; Fazaa, B.; Ben Osman, A.; Zourabichvili, O.; Cazeau, C.; Coubetergues, H.; Picot, S.; Bienvenu, A. L.; Voisard, J. J. Dermatology 2013, 227, 157-164.
  39. Molecular diagnosis by real-time PCR of Leishmania isolated from the Phlebotomus vector. Frahtia-Benotmane, K.; Mihoubi, I.; Picot, S. Med. Sante Trop. 2013, 23, 230.
  40. Digestive parasitosis: giardiasis taeniasis, ascariasis, enterobiasis, amoebiasis, hydatidosis. Picot S. Rev Prat. 2013, 63, 253-258.
  41. Plasmodium vivax malaria: a re-emerging threat for temperate climate zones? Petersen, E.; Severini, C.; Picot, S. Travel. Med. Infect. Dis. 2013, 11, 51-59.
  42. Candida albicans and non-Candida albicans fungemia in an institutional hospital during a decade. Parmeland, L.; Gazon, M.; Guerin, C.; Argaud, L.; Lehot, J. J.; Bastien, O.; Allaouchiche, B.; Michallet, M.; Picot, S.; Bienvenu, A. L. . 2013, 51, 33-37.
  43. Estimation of the incubation period of invasive aspergillosis by survival models in acute myeloid leukemia patients. Bénet, T.; Voirin, N.; Nicolle, M. C.; Picot, S.; Michallet, M.; Vanhems, P. Med. Mycol. 2013, 51,214-218.
  44. Ophthalmic outcomes of congenital toxoplasmosis followed until adolescence. Wallon, M.; Garweg, J. G.; Abrahamowicz, M.; Cornu, C.; Vinault, S.; Quantin, C.; Bonithon-Kopp, C.; Picot, S.; Peyron, F.; Binquet, C. Pediatrics 2014, 133, e601-e608.
  45. Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. Parize, P.; Billaud, S.; Bienvenu, A. L.; Bourdy, S.; le Pogam, M. A.; Reix, P.; Picot, S.; Robert, R.; Lortholary, O.; Bouchara, J. P.; Durieu, I. J. Cyst. Fibros. 2014, 13, 667-673.
  46. New antimalarial drugs: who cares? Picot, S.; Loiseau, P. M.; Bienvenu, A. L. Curr. Top. Med. Chem. 2014, 14, 1637-1642.